Novo Nordisk recently announced a $30-million commitment to help expand opportunities for young Syrian refugees living in Jordan. Novo Nordisk Foundation CEO Mads Krogsgaard Thomsen spoke about the grant and how they hope it helps create a brighter future for Syrian children.
Share
